Continuous Fetal Monitoring During Vacuum Delivery
Information source: Hadassah Medical Organization
Information obtained from ClinicalTrials.gov on October 19, 2009
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Vacuum Delivery
Intervention: Agit Vacuum (Device)
Phase: N/A
Status: Not yet recruiting
Sponsored by: Hadassah Medical Organization Official(s) and/or principal investigator(s):
David Mankuta, MD, Study Chair, Affiliation: Hadassah
Overall contact:
David Mankuta, MD, Phone: 02 6776111
Summary
The investigators have added an additional electrode to the vacuum device for birth in which
they can monitor the fetus during delivery.
Clinical Details
Official title: Continuous Fetal Monitoring During Vacuum Delivery an Addition of a New Device
Study design: Diagnostic, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study
Primary outcome: Quality of fetal heart rate monitoring in both arms
Detailed description:
The investigators have added an additional electrode to the vacuum device for birth in which
they can monitor the fetus during delivery. The electrode is a standard one inserted in the
vacuum device.
Eligibility
Minimum age: N/A.
Maximum age: 1 Day.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- All fetuses at vacuum delivery
Exclusion Criteria:
- None
Locations and Contacts
David Mankuta, MD, Phone: 02 6776111
Hadassah Ein Kerem, Jerusalem, Israel
Additional Information
Starting date: September 2009
Ending date: December 2010
Last updated: August 10, 2009
|
